XSHE
300165
Market cap367mUSD
Oct 09, Last price
4.98CNY
1D
0.20%
1Q
-2.16%
Jan 2017
-50.20%
IPO
-44.01%
Name
Jiangsu Skyray Instrument Co Ltd
Chart & performance
P/E
—
P/S
3.99
EPS
—
Div yield, %
—
Shrs. gr., 5y
0.07%
Rev. gr., 5y
-16.69%
Revenues
619m
-27.26%
Net income
-233m
L+139.25%
CFO
204m
+83.46%
Dividend
Jun 24, 20210.009 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiangsu Skyray Instrument Co., Ltd. provides instruments in spectroscopy and chromatography fields. It also offers spectrometer comprising gold, alloy, mineral, soil, oil, and food analyzer; RoHS tester, and coating thickness measurement instruments. In addition, the company provides atomic absorption spectrometer, mass spectrometry, chromatograph, metal analyzer, carbon and sulfur analyzer, sample preparation system, optical metrology, and skyray instruments. Further, it offers COVID-19 test kits. The company serves electronics, electric appliances, jewelries, toys, food, construction material, metallurgy, minerals, plastic, petroleum, oil, chemistry, medicine, and other sectors. Jiangsu Skyray Instrument Co., Ltd. was founded in 2006 and is based in Kunshan, China.
Key people
Qiao Li
Deputy General Manager · since 2023
Xiaoping Li
Deputy General Manager · since 2023
Yue Ma
Deputy General Manager · since 2022
Tingliang Xiao
Deputy General Manager, Company Secretary · since 2023
Jianqiang Che
Director · since 2013
Guorong Liao
Director · since 2024
Kaizhou Ling
Director · since 2023
Gang Ying
General Manager, Director · since 2008
Xiumei Zhang
Director · since 2024
Weimin Mo
Independent Director · since 2023
Yujin Qian
Independent Director · since 2023
Xin Zhang
Independent Director · since 2021
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||